Seven Eight Capital, LP Inovio Pharmaceuticals, Inc. Transaction History

Seven Eight Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$2.97 - $5.2 $583,162 - $1.02 Million	-196,351 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $728,854 - $1.09 Million	-146,063 Reduced 42.66%	196,351 $980,000
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $1.6 Million - $2.17 Million	224,144 Added 189.52%	342,414 $2.45 Million
Q2 2021 Aug 13, 2021	SELL	$6.23 - $10.03 $1.37 Million - $2.21 Million	-220,331 Reduced 65.07%	118,270 $1.1 Million
Q4 2020 Feb 09, 2021	BUY	$8.5 - $12.85 $2.71 Million - $4.09 Million	318,539 Added 1587.77%	338,601 $3 Million
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $191,993 - $542,677	20,062 New	20,062 $233,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $1.41B
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Seven Eight Capital, LP with notifications on news.